Bioray Biotech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bioray Biotech Co Ltd

Watchlist Manager

Watchlist

Price: 16.9 TWD -4.52% Market Closed

Market Cap: NT$508.5m

B	Bioray Biotech Co Ltd TPEX:7561	TW
	Meganet Corp OTC:MGNT	US
	Summi (Group) Holdings Ltd HKEX:756	HK
T	Trescon Ltd BSE:532159	IN
C	ConectiSys Corp OTC:CONC	US
N	Norvista Capital Corp XTSX:OC	CA
A	Anand Rayons Ltd BSE:542721	IN
	Robot Home Inc TSE:1435	JP
C	Canter Resources Corp OTC:CNRCF	CA
	Polaris Northstar Capital Corp F:L6V	CA

Profitability Summary

Bioray Biotech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

47%

Sustainable 3Y Average Gross Margin

41%

Gross Margin is Increasing

41% > 47%

Healthy Operating Margin

15%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-6% > 15%

Healthy Net Margin

13%

Negative 3Y Average Net Margin

Net Margin is Increasing

-3% > 13%

Exceptional Free Cash Flow Margin

14%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-1%

ROIC is Increasing